The treatment of severe forms of myasthenia gravis

Functional Neurology

Volumn 13, Issue 3, 1998, Pages 231-237

  Iani, Cesare ^a,c   Caramia, Maria ^a   Morosetti, Massimo ^a   Loberti, Marco ^a   Palmieri, Maria Giuseppina ^a   Meloni, Carlo ^b   Gallucci, Massimo Taccone ^a   Casciani, Carlo Umberto ^a   Bernardi, Giorgio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Myasthenia gravis; Myasthenic crisis; Plasma exchange; Steroids and plasmapheresis; Steroids in myasthenia

Indexed keywords

PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MYASTHENIA GRAVIS; PLASMAPHERESIS; SCORING SYSTEM; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; AUTOIMMUNE DISEASES; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PHONATION; PLASMA EXCHANGE; PLASMAPHERESIS; PREDNISONE; TREATMENT OUTCOME;

EID: 0031759928     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kurtzke JF, Kurland LT. Chapter 66: the epidemiology of neurologic diseases. In: Joynt RJ ed Clinical Neurology (Rev. Ed) Vol 4. Philadelphia; J.B. Lippincott 1992: 80-88
2. Osserman KE. Myasthenia Gravis. New York; Grune & Stratton 1958:79-82
3. Sanders DB, Scoppetta C. The treatment of patients with myasthenia gravis. In: Neurologic Clinics (vol. 12) Philadelphia; Sounders 1994:343-368
4. Drachman DB. Myasthenia gravis: Review article. N Engl J Med 1994;330:1797-1810
5. Dau PC. Response to plasmapheresis and immunosuppressive drug therapy in 60 myasthenia gravis patients. Ann N Y Acad Sci 1981;337:700-708
6. Antozzi C, Gemma M, Regi B et al. A short plasma exchange protocol is effective in severe myasthenia gravis. J Neurol 1991; 238:103-107
7. Dau PC, Lindstrom JM, Cassel CK, Denys EH, Shev EE, Spitler LE. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med 1977;24: 1134-1140
8. Mantegazza R, Antozzi C, Peluchetti D, Sghirlanzoni A, Cornelio F. Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. J Neurol 1988;235:449-453
9. Pinching AJ, Peters DK, Newsom-Davis J. Remission of myasthenia gravis following plasma exchange. Lancet 1976;ii:1373-1376
10. Keesey J, Buffkin D, Kebo D, Ho W, Herrmann C Jr. Plasma exchange alone as therapy for myasthenia gravis. Ann N Y Acad Sci 1981;377:729-743
11. Nielsen VK, Paulson OB, Rosenkvist J, Holsoe E, Lefvert AK. Rapid improvement of myasthenia gravis after plasma exchange. Ann Neurol 1982;11:160-169
12. Milner-Brown HS, Miller RG. Time course of improved neuromuscular function following plasma exchange alone and plasma exchange with prednisone/azathioprine in myasthenia gravis. J Neurol Sci 1982;57:357-368
13. Newsom-Davis J, Wilson SG, Vincent A. Long-term effects of repeated plasma exchange in myasthenia gravis. Lancet 1979; i:464-468
14. Grob D, Simpson D, Mitsumoto H et al. Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 1995; 45:338-344
15. Morosetti M, Meloni C, Taccone Gallucci M et al. Plasmapheresis versus plasmaperfusion in acute Guillain Barré syndrome. ASAID J 1994;40 (Suppl 3):638-642
16. Seybold ME, Drachman DB. Gradually increasing doses of prednisone in myasthenia gravis: reducing the hazards of treatment. N Engl J Med 1974;290:81-84